BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Police Documents Reveal Details Of Allegations Against Seagen Founder

  Police documents reveal a May 2 dated TRO against Siegall concerning a fourth degree domestic violence gross misdemeanor charge.

  May 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Industry Experts Predict Biologics CDMO Market Will Hit $31M By 2030

  A recent research report points to the CDMO market heating up. P&S projected the global biologics CDMO market would hit $31.839 million by 2030.

  May 12, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  How to Negotiate Pay As a Remote Employee

  If you’re ready to start earning the salary you deserve, here are some tips to help you recognize your worth and negotiate pay as a remote employee.

  May 12, 2022

   · 

  4 min read

   · 

  Franklin Carpenter
• 

  Policy

  AbbVie, Teva May Pay $5 Billion To Settle Opioid Lawsuit

  AbbVie and Teva are reportedly ready to pay over $5 billion to quiet the over 3,500 opioid liability lawsuits filed against them over their painkillers.

  May 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Business

  BioSpace Movers & Shakers: Singular Genomics, Marengo, Ventyx, Caribou and More

  Life sciences and biopharma companies strengthen their leadership teams and boards with these Movers & Shakers.

  May 12, 2022

   · 

  8 min read

   · 

  Alex Keown
• 

  Drug Development

  TCR² Looks Ahead to Key Year for Lead Therapeutic Candidate

  TCR² Therapeutics provided updates regarding the 2022 first quarter financial results and progress made towards regulatory approval for gavo-cel and TC-510.

  May 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Drug Development

  BMS & BridgeBio Team Up in Nearly $1B Oncology Pact

  BridgeBio announced it has signed an exclusive deal with Bristol-Myers Squibb to develop and commercialize a potential treatment for cancer.

  May 12, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Drug Development

  Stealth Clinches Orphan Drug Designation in DMD

  Stealth BioTherapeutics has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for elamipretide.

  May 12, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Research Roundup: Stressing Cells May Mitigate Dementia and Another Clue to Parkinson’s Disease

  Tangles of toxic proteins are associated with various dementias, such as Alzheimer’s disease. Often, these tangles are misfolded proteins. Now, researchers have identified a new mechanism that might reverse the build-up of these aggregates.

  May 12, 2022

   · 

  6 min read

   · 

  Mark Terry
• 

  Policy

  Biden Commemorates 1M Lives Lost to COVID, Urges Congress to Act

  On Thursday at the White House, President Biden paid tribute to the 1 million American lives lost due to COVID-19.

  May 12, 2022

   · 

  2 min read

   · 

  Rosemary Scott